Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-11 5:27 pm Sale | 2022-07-07 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 100 100.000% | -57,345,694 (-100.00%) | Filing History |
| 2022-05-23 8:55 pm Purchase | 2022-05-23 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 12,904,378 (+29.04%) | Filing History |
| 2022-03-15 09:00 am Unchanged | 2022-03-15 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing History |
| 2022-02-18 8:47 pm Purchase | 2022-02-17 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 20,982,190 (+57.70%) | Filing History |
| 2022-02-14 11:43 am Sale | 2021-12-31 | 13G | ENTASIS THERAPEUTICS HLDGS INC ETTX | Eventide Asset Management, LLC | 590,602 1.200% | -288,939 (-32.85%) | Filing History |
| 2022-02-01 6:34 pm Purchase | 2022-02-01 | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 26,404,378 (+85.34%) | Filing History |
| 2022-01-18 5:27 pm Purchase | 2022-01-12 | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | TPG GP A, LLC | 1,020,748 2.100% | 1,020,748 (New Position) | Filing History |